Skip to main content

Use of Porcine Thymic Immunomodulator in the Treatment of Chronic Hepatitis B

  • Chapter
  • 57 Accesses

Abstract

Studies of hepatitis B surface antigen (HBsAg) prevalence reveal that more than 100,000,000 healthy persons in the world are actually infected with hepatitis B virus and some of these infections may progress to chronic active hepatitis (CAH).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bach, J.-F., 1977, Thymic hormones and autoimmunity, in: Autoimmunity (N. Talal, ed.), pp. 208–230, Academic Press, New York.

    Google Scholar 

  • Chang, T. F., 1981, Experimental and clinical study of immunomodulatory agents in viral hepatitis B, in: A Corpus of Thymic Hormone Data (Biology Department of Nanjing University, ed.), pp. 53–63, Nanjing University, Nanjing, China.

    Google Scholar 

  • Eddleston, A. L., and Williams, R., 1974, Inadequate antibody response to HBsAg or suppressor T-cell defect in development of active chronic hepatitis, Lancet 2:1543.

    Article  PubMed  CAS  Google Scholar 

  • The First Hospital for Infectious Diseases, 1980, Incorporation of thymic hormones into the treatment of severe viral hepatitis, in: A Corpus of Thymic Hormone Data (Biology Department of Nanjing University, ed.), pp. 35–39, Nanjing, China.

    Google Scholar 

  • Li, F., 1980, Clinical investigation on thymic hormone treatment in viral hepatitis, in: A Corpus ofThymic Hormone Data (Biology Department of Nanjing University, ed.), pp. 45–48, Nanjing, China.

    Google Scholar 

  • Mackay, I. R., 1975, Chronic active hepatitis, in: Immune Disorders (L. Van Der Reis, ed.), pp. 143–177, Freeman, San Francisco.

    Google Scholar 

  • Nanjing Associated Group for Study of Thymic Hormones, 1980, A summary on the clinical application of thymic hormones, in: A Corpus of Thymic Hormone Data (Biology Department of Nanjing University, ed.), pp. 1–8, Nanjing, China.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Sheng, S., Yifeng, J. (1984). Use of Porcine Thymic Immunomodulator in the Treatment of Chronic Hepatitis B. In: Goldstein, A.L. (eds) Thymic Hormones and Lymphokines. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4745-3_54

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4745-3_54

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4747-7

  • Online ISBN: 978-1-4684-4745-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics